Yoshida J - Search Results

1

Wakabayashi T, Natsume A, Yoshida J. Wakabayashi T, et al. Among authors: yoshida j. Nihon Rinsho. 2006 Jul;64(7):1327-32. Nihon Rinsho. 2006. PMID: 16838652 Review. Japanese.

2

[Pineal lesion tumors (germinoma)].

Hatano H, Wakabayashi T, Yoshida J. Hatano H, et al. Among authors: yoshida j. Nihon Rinsho. 2006 May 28;Suppl 1:178-82. Nihon Rinsho. 2006. PMID: 16776121 Review. Japanese. No abstract available.

3

A combination of IFN-beta and temozolomide in human glioma xenograft models: implication of p53-mediated MGMT downregulation.

Natsume A, Wakabayashi T, Ishii D, Maruta H, Fujii M, Shimato S, Ito M, Yoshida J. Natsume A, et al. Among authors: yoshida j. Cancer Chemother Pharmacol. 2008 Apr;61(4):653-9. doi: 10.1007/s00280-007-0520-x. Epub 2007 Jun 13. Cancer Chemother Pharmacol. 2008. PMID: 17564708

4

Inhibition of Aurora-B function increases formation of multinucleated cells in p53 gene deficient cells and enhances anti-tumor effect of temozolomide in human glioma cells.

Tsuno T, Natsume A, Katsumata S, Mizuno M, Fujita M, Osawa H, Nakahara N, Wakabayashi T, Satoh Y, Inagaki M, Yoshida J. Tsuno T, et al. Among authors: yoshida j. J Neurooncol. 2007 Jul;83(3):249-58. doi: 10.1007/s11060-007-9335-1. Epub 2007 Feb 14. J Neurooncol. 2007. PMID: 17570035

5

A phase I clinical trial of interferon-beta gene therapy for high-grade glioma: novel findings from gene expression profiling and autopsy.

Wakabayashi T, Natsume A, Hashizume Y, Fujii M, Mizuno M, Yoshida J. Wakabayashi T, et al. Among authors: yoshida j. J Gene Med. 2008 Apr;10(4):329-39. doi: 10.1002/jgm.1160. J Gene Med. 2008. PMID: 18220319 Clinical Trial.

6

A multicenter phase I trial of interferon-beta and temozolomide combination therapy for high-grade gliomas (INTEGRA Study).

Wakabayashi T, Kayama T, Nishikawa R, Takahashi H, Yoshimine T, Hashimoto N, Aoki T, Kurisu K, Natsume A, Ogura M, Yoshida J. Wakabayashi T, et al. Among authors: yoshida j. Jpn J Clin Oncol. 2008 Oct;38(10):715-8. doi: 10.1093/jjco/hyn095. Jpn J Clin Oncol. 2008. PMID: 18845525 Clinical Trial.

7

Gene therapy for high-grade glioma: current approaches and future directions.

Natsume A, Yoshida J. Natsume A, et al. Among authors: yoshida j. Cell Adh Migr. 2008 Jul-Sep;2(3):186-91. doi: 10.4161/cam.2.3.6278. Epub 2008 Jul 13. Cell Adh Migr. 2008. PMID: 19262115 Free PMC article. Review.

8

IFN-beta down-regulates the expression of DNA repair gene MGMT and sensitizes resistant glioma cells to temozolomide.

Natsume A, Ishii D, Wakabayashi T, Tsuno T, Hatano H, Mizuno M, Yoshida J. Natsume A, et al. Among authors: yoshida j. Cancer Res. 2005 Sep 1;65(17):7573-9. doi: 10.1158/0008-5472.CAN-05-0036. Cancer Res. 2005. PMID: 16140920

9

[Neurofibromatosis ].

Wakabayashi T, Saito K, Yoshida J. Wakabayashi T, et al. Among authors: yoshida j. Nihon Rinsho. 2005 Sep;63 Suppl 9:164-9. Nihon Rinsho. 2005. PMID: 16201518 Review. Japanese. No abstract available.

10

EGFR mutations in patients with brain metastases from lung cancer: association with the efficacy of gefitinib.

Shimato S, Mitsudomi T, Kosaka T, Yatabe Y, Wakabayashi T, Mizuno M, Nakahara N, Hatano H, Natsume A, Ishii D, Yoshida J. Shimato S, et al. Among authors: yoshida j. Neuro Oncol. 2006 Apr;8(2):137-44. doi: 10.1215/15228517-2005-002. Epub 2006 Jan 20. Neuro Oncol. 2006. PMID: 16510849 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,426 results

Search Page

Filters